Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 40, Issue 1, 1997, Pages 36-46

  Chinn, R J S ^a,b   Wilkinson, I D ^a   Hall Craggs, M A ^a   Paley, M N J ^a   Shortall, E ^a   Carter, S ^a   Kendall, B E ^a   Isenberg, D A ^a   Newman, S P ^a   Harrison, M J G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN SCINTISCANNING; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031036459     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400107     Document Type: Article

References (46)

1. Adelman DC, Saltiel E, Klincnberg JR: The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 15:185-199, 1986
2. Burnstein SL, Janoff L, McCormick K: Neuropsychiatric involvement in systemic lupus erythematosus: case report and review of the literature. J Am Osteopath Assoc 87:626-631, 1987
3. Devinsky O, Petito CK, Alonso DR: Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23:380-384, 1988
4. Feinglass EJ, Arnctt FC, Dorsch CA, Zizic TM, Stevens MB: Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 55:323-339, 1976
5. Lim L, Ron MA, Ormerod IE, David J, Miller DH, Logsdail SJ, Walport MJ, Harding AE: Psychiatric and neurological manifestations in systemic lupus erythematosus. QJM 66:27-38, 1988
6. McCune WJ, Golbus J: Neuropsychiatric lupus. Rheum Dis Clin North Am 14:149-167, 1988
7. Aisen AM, Gabrielsen TO, McCune WJ: MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 144: 1027-1031, 1985
8. Jacobs L, Kinkel PR, Costello PB, Alukal MK, Kinkel WR, Green FA: Central nervous system lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol 15:601-606, 1988
9. McCune WJ, MacGuire A, Aisen A, Gebarski S: Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 31:159-166, 1988
10. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD: Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 48:1014-1022, 1989
11. Stimmler MM, Coletti PM, Quismorio FPJ: Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 22:335-349, 1993
12. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H: Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging: relationship to anticardiolipin antibody. J Rheumatol 21:87-90, 1994
13. Barker PB, Gillard JH, van Zijl PC, Soher BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN: Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 192:723-732, 1994
14. Henriksen O, Gideon P, Sperling B, Olsen TS, Jorgensen HS, Arlien Soborg P: Cerebral lactate production and blood flow in acute stroke. J Magn Reson Imaging 2:511-517, 1992
15. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI: Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 341:630-631, 1993
16. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI: Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117:49-58, 1994
17. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kcndall BE, Shepard JK. Beecham M, Miller RF, Weller IV, Newman SP. Harrison MJG: Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188:119-124, 1993
18. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G: Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509-515, 1993
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schalter JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
20. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A: The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 86:447-458, 1993
21. Paley MN, Chong WK, Wilkinson ID, Shepherd JK, Clews AM, Sweeney BJ, Hall-Craggs MA, Kendall BE, Newman SP, Harrison MJ: Cerebrospinal fluid-intracranial volume ratio measurements in patients with HIV infection: CLASS image analysis technique. Radiology 190:879-886, 1994
22. Jarek MJ, West SG, Baker MR, Rak KM: Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 37: 1609-1613, 1994
23. Miller BL: A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4:47-52, 1991
24. Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, Landon DN, McDonald WI: The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 29:737-745, 1993
25. Jope RS, Jenden DJ: Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res 4:69-82, 1979
26. Pelech SL, Vance DE: Regulation of phosphatidylcholine biosynthesis. Biochim Biophys Acta 779:217-251, 1984
27. Birken DL, Oldendorf WH: N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13:23-31, 1989
28. Taylor Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ: Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9:347-359, 1994
29. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R: Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63, 1989
30. Hennig J, Pfister H, Ernst T, Ott D: Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 5:193-199, 1992
31. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O: The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 11:799-806, 1993
32. Hashimoto T, Tayama M, Miyazaki M, Fujii E, Harada M, Miyoshi H, Kuroda Y: Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 37:398-405, 1995
33. Soher BJ, van Zijl PC, Duyn JH, Barker PB: Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 35:356-363, 1996
34. Wilkinson ID, Hall-Craggs MA, Chong WK, Paley M, Shepherd J, Noble P, Harrison MJG, Weller IVD: Increase in NA/Cr metabolite ratio following antiretroviral drug therapy in AIDS: a case study. Presented at the Twelfth Annual Meeting of the Society of Magnetic Resonance in Medicine. New York, August 1993 (abstract 1560)
35. Carette S, Urowitz MB, Grosman H, St. Louis EL: Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol 9:855-859, 1982
36. Bentson J, Reza M, Winter J, Wilson G: Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 2:16-23, 1978
37. Lagenstein I, Willig RP, Kuhne D: Reversible cerebral atrophy caused by corticotrophin. Lancet 1:1246-1247, 1979
38. Raskin RJ, Schnapf DJ, Mehlman I: Corticosteroid hormonal influence on cranial computerized tomography: observations in the Rhesus monkey. J Rheumatol 10:977-980, 1983
39. Ostrov SG, Quencer RM, Gaylis NB, Altman RD: Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon? Am J Neuroradiol 3:21-23, 1982
40. Sibbitt WL Jr, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA: Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. Am J Neuroradiol 15:923-928, 1994
41. Ames PRJ, Khamashta MA, Hughes GRV: Clinical and therapeutic aspects of antiphospholipid syndrome. Lupus 4 (suppl 1):S23-S25, 1995
42. Rademacher J, Sohngen D, Specker C, Sitzer M, Siebler M, Steinmetz H: Cerebral microembolism in systemic lupus erythematosus (abstract). Cerebrovasc Dis 5:250, 1995
43. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265-271, 1987
44. Mevorach D, Raz E, Steiner I: Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement. Lupus 3:117-121, 1994
45. Hay EM: Psychiatric disorder and cognitive impairment in SLE. Lupus 3:145-148, 1994
46. Sibbitt WL Jr, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL, Sibbitt RR: Spin-spin relaxation of brain tissues in systemic lupus erythematosus: a method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum 38:810-818, 1995